Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
11,817,237
-
Shares change
-
-1,269,381
-
Total reported value, excl. options
-
$20,196,000
-
Value change
-
-$4,061,095
-
Number of buys
-
8
-
Number of sells
-
-17
-
Price
-
$1.65
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2019
36 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q2 2019.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,817,237 shares
of 385,837,333 outstanding shares and own 3.06% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (2,310,955 shares), Paradice Investment Management LLC (1,543,115 shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1,434,110 shares), JANUS HENDERSON GROUP PLC (1,211,177 shares), HEARTLAND ADVISORS INC (884,700 shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (794,209 shares), RENAISSANCE TECHNOLOGIES LLC (685,496 shares), Lapides Asset Management, LLC (655,500 shares), Adirondack Research & Management Inc. (524,689 shares), and MORGAN STANLEY (460,852 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.